Browse > Article
http://dx.doi.org/10.4062/biomolther.2015.200

Inhibitory Effects of Norwogonin, Oroxylin A, and Mosloflavone on Enterovirus 71  

Choi, Hwa Jung (Department of Beauty Science, Kwangju Women's University)
Song, Hyuk-Hwan (Agency for Korea National Food Cluster (AnFC))
Lee, Jae-Sug (Department of Beauty Science, Kwangju Women's University)
Ko, Hyun-Jeong (College of Pharmacy, Kangwon National University)
Song, Jae-Hyoung (College of Pharmacy, Kangwon National University)
Publication Information
Biomolecules & Therapeutics / v.24, no.5, 2016 , pp. 552-558 More about this Journal
Abstract
Severe complications associated with EV71 infections are a common cause of neonatal death. Lack of effective therapeutic agents for these infections underlines the importance of research for the development of new antiviral compounds. In the present study, the anti-EV71 activity of norwogonin, oroxylin A, and mosloflavone from Scutellaria baicalensis Georgi was evaluated using a cytopathic effect (CPE) reduction method, which demonstrated that all three compounds possessed strong anti-EV71 activity and decreased the formation of visible CPEs. Norwogonin, oroxylin A, and mosloflavone also inhibited virus replication during the initial stage of virus infection, and they inhibited viral VP2 protein expression, thereby inhibiting viral capsid protein synthesis. However, ribavirin has a relatively weaker efficacy compared to the other drugs. Therefore, these findings provide important information that will aid in the utilization of norwogonin, oroxylin A, and mosloflavone for EV71 treatment.
Keywords
Enterovirus 71; Antiviral activity; Norwogonin; Oroxylin A; Mosloflavone;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Badran, S. A., Midgley, S., Andersen, P. and Bottiger, B. (2011) Clinical and virological features of enterovirus 71 infections in Denmark, 2005 to 2008. Scand. J. Infect. Dis. 43, 642-648.   DOI
2 Cabrerizo, M., Tarrago, D., Munoz-Almagro, C., Del Amo, E., Dominguez-Gil, M., Eiros, J. M., Lopez-Miragaya, I., Perez, C., Reina, J., Otero, A., Gonzalez, I., Echevarria, J. E. and Trallero, G. (2014) Molecular epidemiology of enterovirus 71, coxsackievirus A16 and A6 associated with hand, foot and mouth disease in Spain. Clin. Microbiol. Infect. 20, O150-O156.   DOI
3 Chang, L. Y., Lee, C. Y., Kao, C. L., Fang, T. Y., Lu, C. Y., Lee, P. I. and Huang, L. M. (2007) Hand, foot and mouth disease complicated with central nervous system involvement in Taiwan in 1980-1981. J. Formos. Med. Assoc. 106, 173-176.   DOI
4 Chang, L. Y., Lin, T. Y., Hsu, K. H., Huang, Y. C., Lin, K. L., Hsueh, C., Shih, S. R., Ning, H. C., Hwang, M. S., Wang, H. S. and Lee, C. Y. (1999) Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 354, 1682-1686.   DOI
5 Chiang, L. C., Chang, J. S., Chen, C. C., Ng, L. T. and Lin, C. C. (2003) Anti-Herpes simplex virus activity of Bidens pilosa and Houttuynia cordata. Am. J. Chin. Med. 31, 355-362.   DOI
6 Choi, H. J., Kim, J. H., Lee, C. H., Ahn, Y. J., Song, J. H., Baek, S. H. and Kwon, D. H. (2009a) Antiviral activity of quercetin 7-rhamnoside against porcine epidemic diarrhea virus. Antiviral Res. 81, 77-81.   DOI
7 Choi, H. J., Lim, C. H., Song, J. H., Baek, S. H. and Kwon, D. H. (2009b) Antiviral activity of raoulic acid from Raoulia australis against Picornaviruses. Phytomedicine 16, 35-39.   DOI
8 De Clercq, E. (2004) Antiviral drugs in current clinical use. J. Clin. Virol. 30, 115-133.   DOI
9 Hagiwara, A., Tagaya, I. and Yoneyama, T. (1978) Epidemic of hand, foot and mouth disease associated with enterovirus 71 infection. Intervirology 9, 60-63.   DOI
10 Kassab, S., Saghi, T., Boyer, A., Lafon, M. E., Gruson, D., Lina, B., Fleury, H. and Schuffenecker, I. (2013) Fatal case of enterovirus 71 infection and rituximab therapy, france, 2012. Emerging Infect. Dis. 19, 1345-1347.
11 Kim, T. W., Kim, J. G., Yang, C., Ki, H., Jo, J. and Ihee, H. (2014) Pump-Probe X-ray Solution Scattering Reveals Accelerated Folding of Cytochrome Upon Suppression of Misligation. Bull. Korean Chem. Soc. 35, 695-696.   DOI
12 Kuo, R. L. and Shih, S. R. (2013). Strategies to develop antivirals against enterovirus 71. Virol. J. 10, 28.   DOI
13 Lamarao, L. M., Maciel, A. M. and Gomes Mde, L. (2003) First isolation of enterovirus 71 (EV-71) from Northern Brazil. Braz. J. Infect. Dis. 7, 278-281.   DOI
14 Lum, L. C., Wong, K. T., Lam, S. K., Chua, K. B., Goh, A. Y., Lim, W. L., Ong, B. B., Paul, G., AbuBakar, S. and Lambert, M. (1998) Fatal enterovirus 71 encephalomyelitis. J. Pediatr. 133, 795-798.   DOI
15 McMinn, P. C. (2002) An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 26, 91-107.   DOI
16 Merovitz, L., Demers, A. M., Newby, D. and McDonald, J. (2000) Enterovirus 71 infections at a Canadian center. Pediatr. Infect. Dis. J. 19, 755-757.   DOI
17 Mizuta, K., Abiko, C., Murata, T., Matsuzaki, Y., Itagaki, T., Sanjoh, K., Sakamoto, M., Hongo, S., Murayama, S. and Hayasaka, K. (2005) Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003. J. Clin. Microbiol. 43, 6171-6175.   DOI
18 Schmidt, N. J., Lennette, E. H. and Ho, H. H. (1974) An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 129, 304-309.   DOI
19 Moghaddam, E., Teoh, B. T., Sam, S. S., Lani, R., Hassandarvish, P., Chik, Z., Yueh, A., Abubakar, S. and Zandi, K. (2014) Baicalin, a metabolite of baicalein with antiviral activity against dengue virus. Sci. Rep. 4, 5452.
20 Oberste, M. S., Maher, K., Kilpatrick, D. R., Flemister, M. R., Brown, B. A. and Pallansch, M. A. (1999) Typing of human enteroviruses by partial sequencing of VP1. J. Clin. Microbiol. 37, 1288-1293.
21 Schuffenecker, I., Mirand, A., Antona, D., Henquell, C., Chomel, J. J., Archimbaud, C., Billaud, G., Peigue-Lafeuille, H., Lina, B. and Bailly, J. L. (2011) Epidemiology of human enterovirus 71 infections in France, 2000-2009. J. Clin. Virol. 50, 50-56.   DOI
22 Song, J., Yeo, S. G., Hong, E. H., Lee, B. R., Kim, J. W., Kim, J., Jeong, H., Kwon, Y., Kim, H., Lee, S., Park, J. H. and Ko, H. J. (2014) Antiviral Activity of Hederasaponin B from Hedera helix against Enterovirus 71 Subgenotypes C3 and C4a. Biomol. Ther. (Seoul) 22, 41-46.   DOI
23 Tan, X., Huang, X., Zhu, S., Chen, H., Yu, Q., Wang, H., Huo, X., Zhou, J., Wu, Y., Yan, D., Zhang, Y., Wang, D., Cui, A., An, H. and Xu, W. (2011) The persistent circulation of enterovirus 71 in People's Republic of China: causing emerging nationwide epidemics since 2008. PLoS ONE 6, e25662.   DOI
24 Venancio, P., Oliveira, M., Silva, R., Conceicao, C. and Brito, M. J. (2013) First case of severe enterovirus 71 infection in Portugal. Pediatr. Infect. Dis. J. 32, 581-582.
25 Xing, W., Liao, Q., Viboud, C., Zhang, J., Sun, J., Wu, J. T., Chang, Z., Liu, F., Fang, V. J., Zheng, Y., Cowling, B. J., Varma, J. K., Farrar, J. J., Leung, G. M. and Yu, H. (2014) Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect. Dis. 14, 308-318.   DOI
26 Wang, S. M., Lei, H. Y., Huang, K. J., Wu, J. M., Wang, J. R., Yu, C. K., Su, I. J. and Liu, C. C. (2003) Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J. Infect. Dis. 188, 564-570.   DOI
27 Wong, K. T., Lum, L. C. and Lam, S. K. (2000) Enterovirus 71 infection and neurologic complications. N. Engl. J. Med. 342, 356-358.   DOI